Navigation Links
Genomas Presents Drug-Specific Genetic Determinants of Statin Safety and Efficacy at the XV International Symposium on Atherosclerosis
Date:6/15/2009

Data Being Used to Develop DNA-Guided Decision Support for Statin Prescription

BOSTON, June 15 /PRNewswire/ -- Genomas, a biomedical company advancing DNA-guided medicine and personalized healthcare, announced its participation at the prestigious XV International Symposium on Atherosclerosis, a meeting held triennially by the International Atherosclerosis Society. Gualberto Ruano, MD, PhD, President of Genomas, will present "Physiogenomic Contours of Statin Safety and Efficacy," a clinical study examining the differences in response to statin drugs based on individual gene variations.

Statins offer effective strategies to reduce cardiovascular disease and improve survival. However, there are clinically relevant safety risks for some patients. Statin-induced neuro-myopathy (SINM) may present as muscle aches, cramps, weakness, and muscle injury. SINM is more frequent at the higher doses required for treating advanced heart disease, and varies in extent between individual statins and from patient to patient. In previously published studies, over 10% of statin patients experienced neuromuscular side effects, causing disruptions in daily life activities, and reduction in regimen adherence.

In this study, 442 outpatients treated with atorvastatin, rosuvastatin and/or simvastatin were studied in lipid clinics at Hartford Hospital (Hartford, CT) and the University of California, San Francisco. Researchers genotyped 384 SNPs (single nucleotide polymorphisms) from 222 cardiometabolic and neuroendocrine genes with a potential role in determining the safety and efficacy of statins. The study was funded in part by a grant from the National Institute of General Medical Sciences of the National Institutes of Health.

"Contrasting quantitatively how the gene polymorphisms associate with clinical responses, we visualize the 'physiogenomic contours' of statin drugs," said Dr. Ru
'/>"/>

SOURCE Genomas
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Latest trinational report presents most complete picture of North American industrial pollution
2. Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281
3. United Spinal Association Presents The 2009 Independence Expo: Improving Life for the Disabled and the Aging
4. Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009
5. Frost & Sullivan Presents LG Electronics IRIS With the 2009 Global Iris Recognition Biometrics Market Customer Value Leadership of the Year Award
6. Sound Surgical Technologies Chief Technology Officer Presents Paper on Focused Ultrasound Technology
7. Prometheus Presents Proprietary Oncology Diagnostic Platform at ASCO Annual Meeting
8. Telik Presents Results at ASCO From ASSIST-5 Trial of TELCYTA in Platinum Refractory and Resistant Ovarian Cancer
9. Lumenis(R) Presents the SlimLine(TM) GI Laser Fiber: The Latest Advancement in Laser Lithotripsy for Gastroenterology
10. Delaware Urologic Associate's, Dr. Peter J. Muench, Presents Advances in Incontinence Treatment with a New Perspective and Outlook
11. AGA Institute presents cutting-edge research during DDW
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... Parker & Sons, Inc. a ... heating, cooling and plumbing contractor services throughout Arizona ... in 2014 with regard to air-conditioning systems. Residential ... known for its incredibly hot summers. Working with ... and details of a wide variety of systems ...
(Date:12/25/2014)... 2014 The report “Nintedanib (Colorectal ... focuses on the current treatment landscape, unmet needs, ... cancer market. Stivarga is a drug which is ... cancer. Boehringer Ingelheim is developing nintedanib (BIBF-1120), an ... refractory CRC in the US, Europe, and Japan. ...
(Date:12/25/2014)... December 26, 2014 Recently, iFitDress.com, the popular ... women, has announced its new selection of black one-shoulder ... on sale now; they are available at discounted prices, up ... “The promotion will last for three weeks only. You know, ... Those who are interested in our new items can visit ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 BambooFlooringChina.com sells ... high quality bamboo flooring. Today, the company announces ... in many styles and colors. , BambooFlooringChina.com is the ... CEO, the promotion is valid until Jan. 20, 2015. ... strips and woven with a natural thread. All the ...
(Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... children with complex chronic illnesses can receive effective, less expensive ... with easy access to a team of dedicated health care ... to become seriously ill and need either hospitalization or a ... an enhanced medical home clinic at the University of Texas ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3
... transparency for quality improvement.CHICAGO, April 6 ... www.siemens.com/healthcare ) will ... with Soarian(R) Quality Measures, enabled by the REMIND(TM) Platform, ... Society (HIMSS) 2009 Annual Conference and Exhibition in Chicago ...
... -- Harris Corporation (NYSE: HRS ) ... www.ctisus.com ) to deliver intuitive navigation to ... allied healthcare professionals who access the site every day ... and is maintained by The Advanced Medical Imaging Laboratory, ...
... (HIMSS,09, Booth #3974) -- Harris Corporation (NYSE: ... $14 million contract by Evolvent Technologies, Inc., to develop ... System,s global Healthcare Artifact and Image Management Solution (HAIMS). ... potential for four one-year incentive options. The announcement ...
... invites customers to just ,have fun, and use social ... 6 Baxa Corporation, a leading developer of technology ... medications, has joined the social media craze by hosting ... Group. More and more healthcare facilities, medical device ...
... ATLANTA, April 6 CryoLife, Inc., (NYSE: ... and tissue processing company, today announced it has ... of Defense (DoD) Appropriations Bill to continue further ... studies of CryoLife,s BioFoam(R) Surgical Matrix, a protein ...
... small study hint at cancer-preventing ability, researcher says , , MONDAY, ... of broccoli sprouts appeared to reduce the risk of stomach ... Gastric cancer thus joins a long list of malignancies for ... diet that contains broccoli -- including cancer of the esophagus, ...
Cached Medicine News:Health News:Siemens Enhances Knowledge-Driven Solutions to Support Provider Quality of Care Initiatives 2Health News:Siemens Enhances Knowledge-Driven Solutions to Support Provider Quality of Care Initiatives 3Health News:Harris Corporation Redesigning Popular Radiology Web Site to Enhance Content Management and Accessibility 2Health News:Harris Corporation Awarded $14 Million Contract to Develop Multi-Hospital Military Health System Network with Image-Sharing Capabilities 2Health News:Baxa Corporation Gets Social With Facebook and LinkedIn 2Health News:Baxa Corporation Gets Social With Facebook and LinkedIn 3Health News:Department of Defense Awards CryoLife $1.7 million to Develop BioFoam Hemostatic Technology 2Health News:Department of Defense Awards CryoLife $1.7 million to Develop BioFoam Hemostatic Technology 3Health News:Broccoli May Ward Off Serious Stomach Ailments 2Health News:Broccoli May Ward Off Serious Stomach Ailments 3
(Date:12/24/2014)...  Advanced Medical Isotope Corporation ("AMIC") (OTCQB: ADMD), a ... development of brachytherapy devices and medical isotopes for ... has filed a de novo submission ... marketing clearance for its patented Y-90 RadioGel(TM) device ... Drug and Cosmetic Act (the "Act").  ...
(Date:12/24/2014)... 23, 2014   Synageva BioPharma Corp. ... developing therapeutic products for rare disorders, today announced ... the Marketing Authorization Application (MAA) for sebelipase alfa ... company,s request for accelerated assessment, which has the ... The MAA, and the Biologics ...
(Date:12/24/2014)... Dec. 23, 2014  The American Diabetes Association ... target for people with diabetes and that all ... doses of statins, in keeping with recent changes ... the American College of Cardiology (ACC) and American ... the most recent changes to the Association,s annual ...
Breaking Medicine Technology:Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4
... May 31, 2011 Reportlinker.com announces that ... in its catalogue: Global ... 2011-2018 http://www.reportlinker.com/p0512284/Global-Market-for-Hormonal-Contraceptives-and-Infertility-Drugs-2011-2018.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication ... over ten key marketed products and indentifies ...
... NEW YORK, May 30, 2011 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p0535949/The-Antibacterials-Market-Outlook-to-2016.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication ... report provides comprehensive coverage of the global ...
Cached Medicine Technology:Reportlinker Adds Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018 2Reportlinker Adds Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018 3Reportlinker Adds Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018 4Reportlinker Adds Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018 5Reportlinker Adds Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018 6Reportlinker Adds Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018 7Reportlinker Adds The Antibacterials Market Outlook to 2016 2Reportlinker Adds The Antibacterials Market Outlook to 2016 3Reportlinker Adds The Antibacterials Market Outlook to 2016 4
... designed to address customer requests for another ... even wider range of clinical applications in ... flow imaging with super-high frame rates to ... a wealth of technological innovations that enhance ...
... In the Innova™ 4100, the ... X-ray system for angiographic imaging, ... piece, non tiled Digital Detector ... reliably provide high resolution imaging ...
... you perform exams from cardiac to angio. ... no compromises. An ideal 31 centimeters square, ... of cardiovascular and interventional imaging. With a ... variety of vascular and interventional procedures. The ...
... vasopressin (AVP), also known as Antidiurectic Hormone ... is transported via exonal flow to the ... AVP secretion is regulated by changes in ... respond to alterations in blood volume or ...
Medicine Products: